Barrett W. Jeffers

2.7k total citations · 1 hit paper
26 papers, 1.9k citations indexed

About

Barrett W. Jeffers is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Barrett W. Jeffers has authored 26 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 8 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in Barrett W. Jeffers's work include Blood Pressure and Hypertension Studies (13 papers), Hormonal Regulation and Hypertension (5 papers) and Cardiovascular Health and Disease Prevention (5 papers). Barrett W. Jeffers is often cited by papers focused on Blood Pressure and Hypertension Studies (13 papers), Hormonal Regulation and Hypertension (5 papers) and Cardiovascular Health and Disease Prevention (5 papers). Barrett W. Jeffers collaborates with scholars based in United States, China and South Korea. Barrett W. Jeffers's co-authors include Robert W. Schrier, Raymond O. Estacio, William R. Hiatt, Jeffrey A. Cohen, Robert H. Eckel, Sharon Travers, Ping Yan, Mary V. Raynolds, Ji‐Guang Wang and Sally P. Stabler and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Barrett W. Jeffers

26 papers receiving 1.8k citations

Hit Papers

The Effect of Nisoldipine... 1998 2026 2007 2016 1998 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Effect of Nisoldipine as Compared with Enalapril on Cardiovascular Outcomes in Patients with Non-Insulin-Dependent Diabetes and Hypertension
    1998 836 citations Raymond O. Estacio, Barrett W. Jeffers et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barrett W. Jeffers United States 15 1.3k 854 272 232 224 26 1.9k
R Holman United Kingdom 5 732 0.6× 959 1.1× 160 0.6× 250 1.1× 172 0.8× 7 1.7k
Patrick Brunel Switzerland 20 1.4k 1.1× 764 0.9× 301 1.1× 277 1.2× 167 0.7× 62 2.0k
Anastasios N. Lasaridis Greece 23 659 0.5× 521 0.6× 377 1.4× 253 1.1× 89 0.4× 54 1.6k
Tage Lysbo Svendsen Denmark 18 1.6k 1.2× 705 0.8× 555 2.0× 313 1.3× 171 0.8× 54 2.5k
Giovanni Cerasola Italy 28 1.2k 1.0× 425 0.5× 474 1.7× 227 1.0× 132 0.6× 93 2.0k
U. Lennart Hulthén Sweden 24 1.0k 0.8× 718 0.8× 353 1.3× 208 0.9× 144 0.6× 71 2.2k
U. Smidt Denmark 25 1.4k 1.1× 1.3k 1.5× 1.2k 4.3× 260 1.1× 267 1.2× 38 2.7k
Santina Cottone Italy 32 1.7k 1.3× 505 0.6× 777 2.9× 390 1.7× 80 0.4× 131 2.9k
Ruth L. Coleman United Kingdom 19 625 0.5× 1.1k 1.3× 136 0.5× 392 1.7× 94 0.4× 60 1.9k
Roberto Gattobigio Italy 25 2.7k 2.1× 670 0.8× 119 0.4× 399 1.7× 127 0.6× 38 3.1k

Countries citing papers authored by Barrett W. Jeffers

Since Specialization
Citations

This map shows the geographic impact of Barrett W. Jeffers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barrett W. Jeffers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barrett W. Jeffers more than expected).

Fields of papers citing papers by Barrett W. Jeffers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barrett W. Jeffers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barrett W. Jeffers. The network helps show where Barrett W. Jeffers may publish in the future.

Co-authorship network of co-authors of Barrett W. Jeffers

This figure shows the co-authorship network connecting the top 25 collaborators of Barrett W. Jeffers. A scholar is included among the top collaborators of Barrett W. Jeffers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barrett W. Jeffers. Barrett W. Jeffers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goulart, Alessandra C., Amrit Ray, Barrett W. Jeffers, et al.. (2020). <p>Systemic Solutions for Addressing Non-Communicable Diseases in Low- and Middle-Income Countries</p>. Journal of Multidisciplinary Healthcare. Volume 13. 693–707. 22 indexed citations
2.
Jeffers, Barrett W. & Duo Zhou. (2017). Relationship Between Visit-to-Visit Blood Pressure Variability (BPV) and Kidney Function in Patients with Hypertension. Kidney & Blood Pressure Research. 42(4). 697–707. 9 indexed citations
3.
Wang, Ji‐Guang, Duo Zhou, & Barrett W. Jeffers. (2017). Predictors of visit-to-visit blood pressure variability in patients with hypertension: an analysis of trials with an amlodipine treatment arm. Journal of the American Society of Hypertension. 11(7). 402–411. 6 indexed citations
4.
Kim, Jung‐Sun, et al.. (2016). EFFECT OF INTER-INDIVIDUAL BLOOD PRESSURE VARIABILITY ON THE PROGRESSION OF ATHEROSCLEROSIS IN CAROTID AND CORONARY ARTERIES: A POST HOC ANALYSIS OF THE NORMALISE AND PREVENT STUDIES. Journal of the American College of Cardiology. 67(13). 2009–2009. 8 indexed citations
5.
Park, Sungha, et al.. (2016). Effect of visit-to-visit blood pressure variability on cardiovascular events in patients with coronary artery disease and well-controlled blood pressure. Journal of the American Society of Hypertension. 10(10). 799–810. 9 indexed citations
6.
Kim, Jung‐Sun, et al.. (2016). Effect of inter-individual blood pressure variability on the progression of atherosclerosis in carotid and coronary arteries: apost hocanalysis of the NORMALISE and PREVENT studies. European Heart Journal - Cardiovascular Pharmacotherapy. 3(2). pvw019–pvw019. 17 indexed citations
7.
Jeffers, Barrett W., Jeffery Robbins, Rahul Bhambri, & Dalia Wajsbrot. (2015). A Systematic Review on the Efficacy of Amlodipine in the Treatment of Patients With Hypertension With Concomitant Diabetes Mellitus and/or Renal Dysfunction, When Compared With Other Classes of Antihypertensive Medication. American Journal of Therapeutics. 22(5). 322–341. 17 indexed citations
8.
9.
Wang, Ji‐Guang, Ping Yan, & Barrett W. Jeffers. (2014). Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability: Evidence from randomized controlled trials. Journal of the American Society of Hypertension. 8(5). 340–349. 50 indexed citations
10.
Jeffers, Barrett W., Rahul Bhambri, & Jeffery Robbins. (2014). Incremental Blood Pressure–Lowering Effect of Titrating Amlodipine for the Treatment of Hypertension in Patients Including Those Aged ≥55 Years. American Journal of Therapeutics. 22(4). 278–287. 2 indexed citations
11.
Foody, JoAnne M., Amie T. Joyce, Barrett W. Jeffers, Larry Z. Liu, & Joshua S. Benner. (2010). A Large Observational Study of Cardiovascular Outcomes Associated With Atorvastatin or Simvastatin Therapy in Hypertensive Patients Without Prior Cardiovascular Disease. American Journal of Therapeutics. 18(2). 110–116. 3 indexed citations
12.
Foody, JoAnne M., Amie T. Joyce, Barrett W. Jeffers, Larry Z. Liu, & Joshua S. Benner. (2008). A large observational study of cardiovascular outcomes associated with atorvastatin or simvastatin therapy in diabetic patients without prior cardiovascular disease. Diabetes Research and Clinical Practice. 82(1). e13–e15. 1 indexed citations
13.
Cohen, Jeffrey A., et al.. (2001). Increasing homocysteine levels and diabetic autonomic neuropathy. Autonomic Neuroscience. 87(2-3). 268–273. 29 indexed citations
14.
Estacio, Raymond O., et al.. (2000). Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.. PubMed. 23 Suppl 2. B54–64. 496 indexed citations
15.
Jeffers, Barrett W., et al.. (1999). Determinants of energy expenditure in ventilated preterm infants. Journal of Perinatal Medicine. 27(6). 465–72. 15 indexed citations
16.
Stabler, Sally P., Raymond O. Estacio, Barrett W. Jeffers, et al.. (1999). Total homocysteine is associated with nephropathy in non—insulin-dependent diabetes mellitus. Metabolism. 48(9). 1096–1101. 61 indexed citations
17.
Cohen, Jeffrey A., et al.. (1998). Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non-insulin-dependent diabetes mellitus (NIDDM). Muscle & Nerve. 21(1). 72–80. 84 indexed citations
18.
Mehler, Philip S., et al.. (1998). Smoking as a risk factor for nephropathy in non-insulin-dependent diabetics. Journal of General Internal Medicine. 13(12). 842–845. 25 indexed citations
19.
Estacio, Raymond O., et al.. (1998). The Effect of Nisoldipine as Compared with Enalapril on Cardiovascular Outcomes in Patients with Non-Insulin-Dependent Diabetes and Hypertension. New England Journal of Medicine. 338(10). 645–652. 836 indexed citations breakdown →
20.
Travers, Sharon, et al.. (1998). Insulin-Like Growth Factor Binding Protein-I Levels Are Strongly Associated with Insulin Sensitivity and Obesity in Early Pubertal Children1. The Journal of Clinical Endocrinology & Metabolism. 83(6). 1935–1939. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R Holman Breakdown of academic impact, for papers by Patrick Brunel Breakdown of academic impact, for papers by Anastasios N. Lasaridis Breakdown of academic impact, for papers by Tage Lysbo Svendsen Breakdown of academic impact, for papers by Giovanni Cerasola Breakdown of academic impact, for papers by U. Lennart Hulthén Breakdown of academic impact, for papers by U. Smidt Breakdown of academic impact, for papers by Santina Cottone Breakdown of academic impact, for papers by Ruth L. Coleman Breakdown of academic impact, for papers by Roberto Gattobigio
Rankless by CCL
2026